Qiagen (QGEN) Capital Expenditures (2010 - 2026)
Qiagen (QGEN) posted Capital Expenditures of -$46.9 million for Q1 2026, up 76.68% sequentially from -$201.0 million in Q4 2025, and down 6.79% YoY from -$50.3 million in Q1 2025.
Qiagen (QGEN) Capital Expenditures (2010 - 2026) Analysis & Trends
Qiagen has reported Capital Expenditures for 16 years, with the latest figure at -$46.9 million in Q1 2026.
- Quarterly Capital Expenditures fell 6.79% year-over-year to -$46.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$333.9 million (down 14.12% YoY) and the FY2025 annual result came in at $201.0 million, up 20.26% from the prior year.
- Capital Expenditures improved to -$46.9 million in Q1 2026 per QGEN's latest filing, from -$201.0 million in the prior quarter.
- Over five years, Capital Expenditures peaked at -$24.9 million in Q3 2022 and troughed at -$201.0 million in Q4 2025.
- A 5-year average of -$66.3 million and a median of -$40.0 million in 2025 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2022 and 2023: Capital Expenditures jumped 48.27% in 2022, then sank 44.24% in 2023.
- Over 5 years, Capital Expenditures stood at -$129.0 million in 2022, then retreated by 16.28% to -$150.0 million in 2023, then fell by 11.33% to -$167.0 million in 2024, then fell by 20.36% to -$201.0 million in 2025, then jumped by 76.68% to -$46.9 million in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered -$46.9 million, -$201.0 million, and -$46.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 450.00 Mn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 269.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 63.43 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 76.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 198.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 24.65 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 40.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 27.79 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 131.60 Mn |
| 10 | Qiagen | 9.49 Bn | 8.72 Bn | - | -42.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -42.93 Mn |
| Jun 30, 2026 | -42.93 Mn |
| Mar 31, 2026 | -46.88 Mn |
| Mar 31, 2026 | -46.88 Mn |
| Dec 31, 2025 | -201.00 Mn |
| Dec 31, 2025 | -201.00 Mn |
| Sep 30, 2025 | -46.05 Mn |
| Sep 30, 2025 | -46.05 Mn |
| Jun 30, 2025 | -40.00 Mn |
| Jun 30, 2025 | -40.00 Mn |
| Mar 31, 2025 | -43.90 Mn |
| Mar 31, 2025 | -43.90 Mn |
| Dec 31, 2024 | -167.00 Mn |
| Dec 31, 2024 | -167.00 Mn |
| Sep 30, 2024 | -43.71 Mn |
| Sep 30, 2024 | -43.71 Mn |
| Jun 30, 2024 | -38.00 Mn |
| Jun 30, 2024 | -38.00 Mn |
| Mar 31, 2024 | -36.54 Mn |
| Mar 31, 2024 | -36.54 Mn |